August 27, 2021
Wakamoto Pharmaceutical said on August 26 that it has launched a PIII clinical trial for its ophthalmic surgical drug MaQaid (triamcinolone acetonide) in China aiming to obtain regulatory approval in the country. The PIII program is designed to investigate the...read more